Similar articles for PMID: 24268519

Year	Number of Results
1997	1
1998	1
2000	1
2002	3
2003	3
2005	2
2006	2
2007	4
2008	1
2009	2
2010	5
2011	5
2012	6
2013	7
2014	9
2015	6
2016	9
2017	9
2018	10
2019	6
2020	10
2021	10
2022	2
2023	1
2024	0

1

Lipid mediators in immune dysfunction after severe inflammation.

Fullerton JN, O'Brien AJ, Gilroy DW. Fullerton JN, et al. Trends Immunol. 2014 Jan;35(1):12-21. doi: 10.1016/j.it.2013.10.008. Epub 2013 Nov 21. Trends Immunol. 2014. PMID: 24268519 Free PMC article. Review.

2

Gene Expression of Proresolving Lipid Mediator Pathways Is Associated With Clinical Outcomes in Trauma Patients.

Orr SK, Butler KL, Hayden D, Tompkins RG, Serhan CN, Irimia D. Orr SK, et al. Crit Care Med. 2015 Dec;43(12):2642-50. doi: 10.1097/CCM.0000000000001312. Crit Care Med. 2015. PMID: 26488221 Free PMC article.

3

Prostanoids and Resolution of Inflammation - Beyond the Lipid-Mediator Class Switch.

Schmid T, Brüne B. Schmid T, et al. Front Immunol. 2021 Jul 12;12:714042. doi: 10.3389/fimmu.2021.714042. eCollection 2021. Front Immunol. 2021. PMID: 34322137 Free PMC article. Review.

4

Eicosanoid storm in infection and inflammation.

Dennis EA, Norris PC. Dennis EA, et al. Nat Rev Immunol. 2015 Aug;15(8):511-23. doi: 10.1038/nri3859. Epub 2015 Jul 3. Nat Rev Immunol. 2015. PMID: 26139350 Free PMC article. Review.

5

Lipid mediators in inflammatory disorders.

Heller A, Koch T, Schmeck J, van Ackern K. Heller A, et al. Drugs. 1998 Apr;55(4):487-96. doi: 10.2165/00003495-199855040-00001. Drugs. 1998. PMID: 9561339 Free PMC article. Review.

6

Key roles for lipid mediators in the adaptive immune response.

Duffney PF, Falsetta ML, Rackow AR, Thatcher TH, Phipps RP, Sime PJ. Duffney PF, et al. J Clin Invest. 2018 Jul 2;128(7):2724-2731. doi: 10.1172/JCI97951. Epub 2018 Jul 2. J Clin Invest. 2018. PMID: 30108196 Free PMC article. Review.

7

Proresolving lipid mediators and mechanisms in the resolution of acute inflammation.

Buckley CD, Gilroy DW, Serhan CN. Buckley CD, et al. Immunity. 2014 Mar 20;40(3):315-27. doi: 10.1016/j.immuni.2014.02.009. Immunity. 2014. PMID: 24656045 Free PMC article. Review.

8

Does promoting resolution instead of inhibiting inflammation represent the new paradigm in treating infections?

Dalli J. Dalli J. Mol Aspects Med. 2017 Dec;58:12-20. doi: 10.1016/j.mam.2017.03.007. Epub 2017 Apr 5. Mol Aspects Med. 2017. PMID: 28365269 Free article. Review.

9

Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases.

Perucci LO, Sugimoto MA, Gomes KB, Dusse LM, Teixeira MM, Sousa LP. Perucci LO, et al. Expert Opin Ther Targets. 2017 Sep;21(9):879-896. doi: 10.1080/14728222.2017.1364363. Epub 2017 Aug 17. Expert Opin Ther Targets. 2017. PMID: 28786708 Review.

10

Proresolving lipid mediators and liver disease.

Clària J, Flores-Costa R, Duran-Güell M, López-Vicario C. Clària J, et al. Biochim Biophys Acta Mol Cell Biol Lipids. 2021 Nov;1866(11):159023. doi: 10.1016/j.bbalip.2021.159023. Epub 2021 Aug 2. Biochim Biophys Acta Mol Cell Biol Lipids. 2021. PMID: 34352389 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

105 results

Results by year